Preeclampsia-like symptoms induced in mice by fetoplacental expression of STOX1 are reversed by aspirin treatment

Hypertension

Volumn 61, Issue 3, 2013, Pages 662-668

  Doridot, Ludivine ^a,b,c   Passet, Bruno ^d   Méhats, Céline ^a,b,c   Rigourd, Virginie ^a,b,c,e   Barbaux, Sandrine ^a,b,c   Ducat, Aurélien ^a,b,c   Mondon, Françoise ^a,b,c   Vilotte, Marthe ^d   Castille, Johann ^d   Breuiller Fouché, Michelle ^a,b,c   Daniel, Nathalie ^f   Le Provost, Fabienne ^d   Bauchet, Anne Laure ^g   Baudrie, Véronique ^h   Hertig, Alexandre ⁱ   Buffat, Christophe ^b,j   Simeoni, Umberto ^j   Germain, Guy ^g   Vilotte, Jean Luc ^d   Vaiman, Daniel ^a,b,c  

^a INSTITUT COCHIN   (France)

^b CNRS   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

^d UMR1313 GÉNÉTIQUE ANIMALE ET BIOLOGIE INTÉGRATIVE   (France)

^e Institut de Puericulture   (France)

^f INRA Institut National de la Recherche Agronomique   (France)

^g INSTITUT DE RADIOPROTECTION ET DE SÛRETÉ NUCLÉAIRE   (France)

^h HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

ⁱ INSERM   (France)

^j HÔPITAL DE LA CONCEPTION   (France)

more..

Author keywords

hypertension; mouse model; preeclampsia; proteinuria; STOX1

Indexed keywords

ACETYLSALICYLIC ACID; ALBUMIN; CREATININE; ENDOGLIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR STOX1; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN; CONTROLLED STUDY; FEMALE; FETOPLACENTAL UNIT; FIBRIN DEPOSITION; GESTATIONAL AGE; HISTOLOGY; HYPERTENSION; IMMUNOHISTOCHEMISTRY; KIDNEY; KIDNEY MALFORMATION; LITTER SIZE; LIVER; LOW DRUG DOSE; MALE; MATERNAL HYPERTENSION; MOUSE; NONHUMAN; PLACENTA; PREECLAMPSIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEINURIA; SPERMATOZOON; TESTIS; TRANSGENE; TRANSGENIC MOUSE;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIHYPERTENSIVE AGENTS; ASPIRIN; CARRIER PROTEINS; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; KIDNEY; MALE; MICE; MICE, TRANSGENIC; PLACENTA; PRE-ECLAMPSIA; PREGNANCY; SEVERITY OF ILLNESS INDEX; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1;

EID: 84874376423     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.111.202994     Document Type: Article

References (37)

1. Sibai BM. Thrombophilia and severe preeclampsia: time to screen and treat in future pregnancies Hypertension. 2005;46:1252-1253.
2. Firoz T, Sanghvi H, Merialdi M, von Dadelszen P. Pre-eclampsia in low and middle income countries. Best Pract Res Clin Obstet Gynaecol. 2011;25:537-548.
3. Goldenberg RL, McClure EM, Macguire ER, Kamath BD, Jobe AH. Lessons for low-income regions following the reduction in hypertension-related maternal mortality in high-income countries. Int J Gynaecol Obstet. 2011;113:91-95.
4. Goldenberg RL, Culhane JF, Iams JD, Romero R. Epidemiology and causes of preterm birth. Lancet. 2008;371:75-84.
5. van Dijk M, Mulders J, Poutsma A, Könst AA, Lachmeijer AM, Dekker GA, Blankenstein MA, Oudejans CB. Maternal segregation of the Dutch preeclampsia locus at 10q22 with a new member of the winged helix gene family. Nat Genet. 2005;37:514-519.
6. van Dijk M, van Bezu J, van Abel D, Dunk C, Blankenstein MA, Oudejans CB, Lye SJ. The STOX1 genotype associated with pre-eclampsia leads to a reduction of trophoblast invasion by alpha-T-catenin upregulation. Hum Mol Genet. 2010;19:2658-2667.
7. van Dijk M, Drewlo S, Oudejans CB. Differential methylation of STOX1 in human placenta. Epigenetics. 2010;5:736-742.
8. Rigourd V, Chauvet C, Chelbi ST, Rebourcet R, Mondon F, Letourneur F, Mignot TM, Barbaux S, Vaiman D. STOX1 overexpression in choriocarcinoma cells mimics transcriptional alterations observed in preeclamptic placentas. PLoS ONE. 2008;3:e3905.
9. Fenstad MH, Johnson MP, Løset M, Mundal SB, Roten LT, Eide IP, Bjørge L, Sande RK, Johansson AK, Dyer TD, Forsmo S, Blangero J, Moses EK, Austgulen R. STOX2 but not STOX1 is differentially expressed in decidua from pre-eclamptic women: data from the Second Nord-Trondelag Health Study. Mol Hum Reprod. 2010;16:960-968.
10. Founds SA, Conley YP, Lyons-Weiler JF, Jeyabalan A, Hogge WA, Conrad KP. Altered global gene expression in first trimester placentas of women destined to develop preeclampsia. Placenta. 2009;30:15-24.
11. Vilotte JL, Soulier S, Stinnakre MG, Massoud M, Mercier JC. Efficient tissue-specific expression of bovine alpha-lactalbumin in transgenic mice. Eur J Biochem. 1989;186:43-48.
12. Meller M, Vadachkoria S, Luthy DA, Williams MA. Evaluation of housekeeping genes in placental comparative expression studies. Placenta. 2005;26:601-607.
13. Vricella LK, Louis JM, Mercer BM, Bolden N. Epidural-associated hypotension is more common among severely preeclamptic patients in labor. Am J Obstet Gynecol. 2012;207:335.e1-335.e7.
14. Maynard SE, Min JY, Merchan J, Lim KH, Li J, Mondal S, Libermann TA, Morgan JP, Sellke FW, Stillman IE, Epstein FH, Sukhatme VP, Karumanchi SA. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest. 2003;111:649-658.
15. Levine RJ, Maynard SE, Qian C, Lim KH, England LJ, Yu KF, Schisterman EF, Thadhani R, Sachs BP, Epstein FH, Sibai BM, Sukhatme VP, Karumanchi SA. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med. 2004;350:672-683.
16. Hu YC, Wang PH, Yeh S, Wang RS, Xie C, Xu Q, Zhou X, Chao HT, Tsai MY, Chang C. Subfertility and defective folliculogenesis in female mice lacking androgen receptor. Proc Natl Acad Sci USA. 2004;101:11209-11214.
17. Gaber LW, Spargo BH, Lindheimer MD. Renal pathology in pre-eclampsia. Baillieres Clin Obstet Gynaecol. 1994;8:443-468.
18. Fogo AB. Renal Diseases in Pregnancy. 6th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2007.
19. Fiaschi E, Naccarato R. The histopathology of the kidney in toxaemia. Serial renal biopsies during pregnancy, puerperium and several years postpartum. Light and electron microscopic and immunofluorescent studies. Virchows Arch A Pathol Pathol Anat. 1968;345:299-309.
20. Iglesias-Platas I, Monk D, Jebbink J, Buimer M, Boer K, van der Post J, Hills F, Apostolidou S, Ris-Stalpers C, Stanier P, Moore GE. STOX1 is not imprinted and is not likely to be involved in preeclampsia. Nat Genet. 2007;39:279-280; author reply 280.
21. Davisson RL, Hoffmann DS, Butz GM, Aldape G, Schlager G, Merrill DC, Sethi S, Weiss RM, Bates JN. Discovery of a spontaneous genetic mouse model of preeclampsia. Hypertension. 2002;39(2 Pt 2):337-342.
22. Ahmed A, Singh J, Khan Y, Seshan SV, Girardi G. A new mouse model to explore therapies for preeclampsia. PLoS ONE. 2010;5:e13663.
23. Kanayama N, Takahashi K, Matsuura T, Sugimura M, Kobayashi T, Moniwa N, Tomita M, Nakayama K. Deficiency in p57Kip2 expression induces preeclampsia-like symptoms in mice. Mol Hum Reprod. 2002;8:1129-1135.
24. Kanasaki K, Palmsten K, Sugimoto H, Ahmad S, Hamano Y, Xie L, Parry S, Augustin HG, Gattone VH, Folkman J, Strauss JF, Kalluri R. Deficiency in catechol-O-methyltransferase and 2-methoxyoestradiol is associated with pre-eclampsia. Nature. 2008;453:1117-1121.
25. Kumasawa K, Ikawa M, Kidoya H, Hasuwa H, Saito-Fujita T, Morioka Y, Takakura N, Kimura T, Okabe M. Pravastatin induces placental growth factor (PGF) and ameliorates preeclampsia in a mouse model. Proc Natl Acad Sci USA. 2011;108:1451-1455.
26. Falcao S, Stoyanova E, Cloutier G, Maurice RL, Gutkowska J, Lavoie JL. Mice overexpressing both human angiotensinogen and human renin as a model of superimposed preeclampsia on chronic hypertension. Hypertension. 2009;54:1401-1407.
27. Balta O, Boztosun A, Deveci K, Gulturk S, Ekici F, Kaya A, Cetin A, Cetin M. Reduced uterine perfusion pressure model is not successful to mimic severe preeclampsia. Placenta. 2011;32:675-680.
28. Imasawa T, Nishiwaki T, Nishimura M, Shikama N, Matsumura R, Nagai M, Soyama A, Koike K, Kitamura H, Joh K. A case of "pure" preeclampsia with nephrotic syndrome before 15 weeks of gestation in a patient whose renal biopsy showed glomerular capillary endotheliosis. Am J Kidney Dis. 2006;48:495-501.
29. Bujold E, Roberge S, Lacasse Y, Bureau M, Audibert F, Marcoux S, Forest JC, Giguère Y. Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: a meta-analysis. Obstet Gynecol. 2010;116(2 Pt 1):402-414.
30. Beaufils M, Uzan S, Donsimoni R, Colau JC. Prevention of pre-eclampsia by early antiplatelet therapy. Lancet. 1985;1:840-842.
31. Wallenburg HC, Dekker GA, Makovitz JW, Rotmans P. Low-dose aspirin prevents pregnancy-induced hypertension and pre-eclampsia in angiotensin-sensitive primigravidae. Lancet. 1986;1:1-3.
32. Bakhti A, Vaiman D. Prevention of gravidic endothelial hypertension by aspirin treatment administered from the 8th week of gestation. Hypertens Res. 2011;34:1116-1120.
33. Roberge S, Giguère Y, Villa P, Nicolaides K, Vainio M, Forest JC, von Dadelzen P, Vaiman D, Tapp S, Bujold E. Early administration of lowdose aspirin for the prevention of severe and mild preeclampsia: a systematic review and meta-analysis. Am J Perinatol. 2012;29:551-556.
34. Mercer BM, Crocker LG, Pierce WF, Sibai BM. Clinical characteristics and outcome of twin gestation complicated by preterm premature rupture of the membranes. Am J Obstet Gynecol. 1993;168:1467-1473.
35. Constância M, Hemberger M, Hughes J, Dean W, Ferguson-Smith A, Fundele R, Stewart F, Kelsey G, Fowden A, Sibley C, Reik W. Placentalspecific IGF-II is a major modulator of placental and fetal growth. Nature. 2002;417:945-948.
36. Lopez MF, Dikkes P, Zurakowski D, Villa-Komaroff L. Insulin-like growth factor II affects the appearance and glycogen content of glycogen cells in the murine placenta. Endocrinology. 1996;137:2100-2108.
37. Varrault A, Gueydan C, Delalbre A, Bellmann A, Houssami S, Aknin C, Severac D, Chotard L, Kahli M, Le Digarcher A, Pavlidis P, Journot L. Zac1 regulates an imprinted gene network critically involved in the control of embryonic growth. Dev Cell. 2006;11:711-722.